A combination of ascorbic acid and α-tocopherol to test the effectiveness and safety in the fragile X syndrome: study protocol for a phase II, randomized, placebo-controlled trial

BACKGROUND: Fragile X syndrome (FXS) is an inherited neurodevelopmental condition characterised by behavioural, learning disabilities, phisical and neurological symptoms. In addition, an important degree of comorbidity with autism is also present. Considered a rare disorder affecting both genders, i...

Descripción completa

Detalles Bibliográficos
Autores principales: de Diego-Otero, Yolanda, Calvo-Medina, Rocio, Quintero-Navarro, Carolina, Sánchez-Salido, Lourdes, García-Guirado, Francisco, del Arco-Herrera, Ignacio, Fernández-Carvajal, Isabel, Ferrando-Lucas, Teresa, Caballero-Andaluz, Rafaela, Pérez-Costillas, Lucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168067/
https://www.ncbi.nlm.nih.gov/pubmed/25187257
http://dx.doi.org/10.1186/1745-6215-15-345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168067/
https://www.ncbi.nlm.nih.gov/pubmed/25187257
http://dx.doi.org/10.1186/1745-6215-15-345

Ejemplares similares